Internal Medicine, Pulmonary Disease · Herrin, IL
NPI
1306387774
Since 2017
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
217 S Park Ave, Suite1
Herrin, IL, 62948
Phone (618) 942-7402
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
1,481 services
Medicare patients, 2024
569
Average age 71
Drug cost, 2024
$1.6M
3,915 prescriptions
Company payments, 2025
$18.85
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Walid Y Halees was code 99214 (office e&m - established), 365 times for 203 patients. In total Walid Y Halees billed 1,481 services in 21 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 365 | 203 | $68.24 | $25K |
| 94060 Pulmonary Function Testing | Facility | 232 | 231 | $7.20 | $1,671 |
| 94726 Pulmonary Function Testing | Facility | 189 | 188 | $8.34 | $1,577 |
| 94729 Pulmonary Function Testing | Facility | 185 | 184 | $6.29 | $1,164 |
| 99214 Office E&M - Established | Office | 90 | 54 | $80.57 | $7,252 |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 87 | 26 | $0.04 | $3.56 |
| 94010 Pulmonary Function Testing | Facility | 64 | 62 | $5.79 | $370 |
| 99204 Office E&M - New | Facility | 50 | 50 | $88.04 | $4,402 |
| 94618 Pulmonary Function Testing | Facility | 36 | 36 | $15.61 | $562 |
| 94060 Pulmonary Function Testing | Office | 30 | 28 | $26.84 | $805 |
| 99205 Office E&M - New | Facility | 28 | 28 | $140.60 | $3,937 |
| 94640 Treatment - Miscellaneous | Office | 18 | 18 | $5.51 | $99.11 |
| 94070 Pulmonary Function Testing | Facility | 15 | 15 | $19.48 | $292 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $100.63 | $1,308 |
| 99232 Hospital E&M - Subsequent | Facility | 13 | 12 | $54.48 | $708 |
By year: 2022 $52K for 1,364 services; 2023 $48K for 1,238 services; 2024 $54K for 1,481 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36600 General Laboratory | 14 | 13 | $11.88 | $166 |
Medicare prescription drug claims, 2024
In 2024, the drug Walid Y Halees prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,160 prescriptions and refills. In total Walid Y Halees wrote 3,915 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,160 | 1,297 | 190 | $819K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 417 | 458 | 109 | $16K |
| Prednisone Generic | 252 | 290 | 124 | $875 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 247 | 274 | 61 | $170K |
| Breo Ellipta Fluticasone/Vilanterol | 172 | 180 | 30 | $69K |
| Dulera Mometasone/Formoterol | 170 | 181 | 38 | $61K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 169 | 192 | 54 | $32K |
| Incruse Ellipta Umeclidinium Bromide | 114 | 126 | 29 | $42K |
| Roflumilast Generic | 103 | 133 | 20 | $9,419 |
| Spiriva Respimat Tiotropium Bromide | 102 | 122 | 28 | $63K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 101 | 111 | 34 | $10K |
| Symbicort Budesonide/Formoterol Fumarate | 92 | 110 | 30 | $25K |
| Doxycycline Hyclate Generic | 92 | 92 | 66 | $563 |
| Azithromycin Generic | 89 | 96 | 52 | $542 |
| Ventolin Hfa Albuterol Sulfate | 78 | 92 | 21 | $6,083 |
Brand drugs: 2,912 claims; generic drugs: 1,003 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Walid Y Halees $18.85 ($18.85 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $18.85.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.